banner
HCV protease inhibitor PSI-6206 13CD3, Purity ≥98%

Cat. No.: X24-07-ZQ171

HCV protease inhibitor PSI-6206 13CD3, Purity ≥98%

Synonym: 1256490-42-2; HCV protease inhibitor; RO-2433 13CD3; GS-331007 13CD3; Sofosbuvir metabolite GS-331007 13CD3

  • CAS Number: 1256490-42-2
  • Compound CID: 58463518
Product Size
1 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
PSI-6206 13CD3 targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
264.23
Molecular Formula
C10H10D3FN2O5
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
PSI-6206 13CD3 is analyzed for its potential to inhibit hepatitis C virus replication by interfering with the viral protease enzyme.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0